Cross‐species chemogenomic profiling reveals evolutionarily conserved drug mode of action
Abstract We present a cross‐species chemogenomic screening platform using libraries of haploid deletion mutants from two yeast species, Saccharomyces cerevisiae and Schizosaccharomyces pombe. We screened a set of compounds of known and unknown mode of action (MoA) and derived quantitative drug score...
Main Authors: | Laura Kapitzky, Pedro Beltrao, Theresa J Berens, Nadine Gassner, Chunshui Zhou, Arthur Wüster, Julie Wu, M Madan Babu, Stephen J Elledge, David Toczyski, R Scott Lokey, Nevan J Krogan |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2010-12-01
|
Series: | Molecular Systems Biology |
Subjects: | |
Online Access: | https://doi.org/10.1038/msb.2010.107 |
Similar Items
-
Computational chemogenomics /
by: Jacoby, Edgar
Published: (2014) -
Chemogenomics : knowledge-based approaches to drug discovery /
by: Jacoby, Edgar
Published: (2006) -
Dissecting a complex chemical stress: chemogenomic profiling of plant hydrolysates
by: Jeffrey M Skerker, et al.
Published: (2013-06-01) -
Chemogenomics and orthology‐based design of antibiotic combination therapies
by: Sriram Chandrasekaran, et al.
Published: (2016-05-01) -
In-silico target prediction by ensemble chemogenomic model based on multi-scale information of chemical structures and protein sequences
by: Su-Qing Yang, et al.
Published: (2023-04-01)